News brief
On 2026/8/11, Elsewhere reported that Chinese biological AI company Xunming Shengke raised USD 100 million in Series B funding, bringing total funding close to USD 200 million. The round was completed in stages, with proceeds supporting biological foundation model R&D and training at scale.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- elsewhere.news ↗Published Aug 11, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年8月11日，据Elsewhere报道，中国生物AI公司寻明生科完成1亿美元B轮融资，累计融资近2亿美元；本轮分阶段完成，资金将用于生物基座模型研发与规模化训练。